Physician profile
Blake Young
NPI 1427727957
$5,932.77
in general payments reported to CMS, 2019-2025
33 companies · $843 in 2025
The $843 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $502 · 2022: $1,167 · 2023: $1,611 · 2024: $1,810 · 2025: $843.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,144 · Education: $119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,144.33 |
| Education | $119.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,242.39 | 2021-2025 | Fasenra, Tezspire, Airsupra |
| Jazz Pharmaceuticals INC. | $779.79 | 2021-2025 | |
| Genzyme Corporation | $472.53 | 2022-2025 | |
| Glaxosmithkline, LLC. | $389.33 | 2022-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Regeneron Healthcare Solutions, INC. | $325.01 | 2022-2025 | Dupixent |
| Axsome Therapeutics, INC. | $280.48 | 2023-2025 | Sunosi |
| Harmony Biosciences LLC | $238.96 | 2021-2025 | Wakix |
| Alexion Pharmaceuticals, INC. | $233.27 | 2021-2023 | Ultomiris |
| Inspire Medical Systems, INC. | $228.10 | 2023-2025 | Inspire |
| Amgen INC. | $205.60 | 2022-2025 | Tezspire |
| Abbvie INC. | $189.38 | 2021-2022 | |
| Avadel Cns Pharmaceuticals, LLC | $184.11 | 2023-2025 | Lumryz |
| Kyowa Kirin, INC. | $121.98 | 2022 | |
| Insmed, INC. | $107.51 | 2023-2025 | Arikayce |
| Idorsia Pharmaceuticals US INC | $102.76 | 2022-2024 | Quviviq |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $102.38 | 2021 | |
| Argenx US, INC. | $101.61 | 2023 | Vyvgart |
| Takeda Pharmaceuticals U.S.A., INC. | $83.90 | 2023-2024 | Glassia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.31 | 2022-2024 | Ofev |
| Mylan Specialty L.P. | $56.96 | 2022-2024 | Yupelri |
| Azurity Pharmaceuticals, INC. | $55.21 | 2023 | Horizant |
| Baxter Healthcare | $50.70 | 2022 | |
| Lilly USA, LLC | $46.87 | 2025 | Zepbound, Mounjaro |
| Verona Pharma, INC. | $37.13 | 2025 | Ohtuvayre |
| Inogen, INC. | $36.50 | 2023-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Pfizer INC. | $34.11 | 2023 | |
| Merck Sharp & Dohme LLC | $33.89 | 2022-2024 | Winrevair |
| 3b Medical, INC. | $29.45 | 2025 | Luna |
| Actelion Pharmaceuticals US, INC. | $22.10 | 2022 | |
| Ani Pharmaceuticals, INC. | $21.69 | 2023 | Purified Cortrophin Gel |
| Fisher & Paykel Healthcare INC | $21.25 | 2022 | |
| Shionogi INC | $21.18 | 2023 | Fetroja |
| Resmed Corp | $18.33 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blake Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.